Three million deaths of children linked to drug resistance

It is believed that more than three million children worldwide have died in 2022 as a result of antibiotic -resistant infection, according to a study by two main experts in child health.

Children in Africa and Southeast Asia are found to be more at risk.

Antimicrobial resistance – known as AMR – when microbes that cause infections develop in a way that is no longer antibiotic drugs.

It was identified as one of the largest public health threats facing the world’s population.

A new study now reveals that Amr is taking children.

Using data from multiple sources, including the World Health Organization (WHO) and the World Bank, according to the reporters of the report that there are more than three million children’s deaths in 2022 linked to drug -resistant infections.

Experts say this new study highlights an increase of more than ten times in the infections related to Amr in children in just three years.

The number could be worse due to the effect of the roaming epidemic.

Antibiotics are used to treat or prevent a large group of bacterial infections – everything from skin infections to pneumonia.

They are sometimes given as a preventive procedure to prevent, instead of treatment, infection – for example if someone suffers from a chemical treatment for cancer.

Antibiotics have no effect on viral infections, though – such as diseases such as common cold, influenza or covid.

But some bacteria have now evolved resistance to some medications, due to excessive use and inappropriate use, while the production of new antibiotics – a long and expensive process – slowly slow.

The main authors of the report, Dr. Yanong Jessica, is from the Children’s Research Institute in Murdoch in Australia, and Professor Herb Harwell from the Clinton to reach health, has a significant growth in the use of antibiotics that are supposed to be only hindered by the most dangerous infections.

Between 2019 and 2021, “antibiotics viewing”, high -risk risks increased by 160 % in Southeast Asia and 126 % in Africa.

During the same period, “reserve antibiotics” – the recent treatments of severe and resistant infections – increased by 45 % in Southeast Asia and 125 % in Africa.

Authors warn that if bacteria developed resistant to these antibiotics, there will be few alternatives, if any, to treat multiple drug -resistant infections.

Professor Harwell presents the results of the European Association for Clinical Microbies and Infectious Diseases in Vienna later this month.

“Amr is a global problem. It affects everyone. We have done this work to really focus on the improper way that Amr affects children,” he said before the event.

“We estimate three million deaths of children all over the world associated with antimicrobial resistance.”

Who describes Amr as one of the most dangerous global health threats We are facing, but we are talking about Vienna, Professor Harwell warns of the lack of easy answers.

“It is a multi -faceted problem that extends to all aspects of medicine and in fact a person’s life,” he said.

“Antibiotics everywhere around us, and end up in our food and the environment, and therefore the exit with one solution is not easy.”

He adds that the best way to avoid resistant infection is to avoid infection completely, which means that there are higher levels of immunization and sanitation for water and hygiene.

“There will be more use of antibiotics because there are more people they need, but we need to make sure to use them appropriately and the correct medications are used.”

The new study “represents a significant and disturbing increase compared to previous data.”

“These results should be an invitation to wake up to global health leaders. Without decisive measures, Amr can undermine contracts for child health, especially in the world’s most vulnerable regions.”